102 related articles for article (PubMed ID: 15863166)
1. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia.
Leo C; Richter C; Horn LC; Schütz A; Pilch H; Höckel M
Gynecol Oncol; 2005 May; 97(2):602-6. PubMed ID: 15863166
[TBL] [Abstract][Full Text] [Related]
2. Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
Leo C; Horn LC; Rauscher C; Hentschel B; Richter CE; Schütz A; Leo CP; Höckel M
Clin Cancer Res; 2007 Feb; 13(4):1149-53. PubMed ID: 17317823
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
4. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy.
Bache M; Holzapfel D; Kappler M; Holzhausen HJ; Taubert H; Dunst J; Hänsgen G
Gynecol Oncol; 2007 Jan; 104(1):139-44. PubMed ID: 16919715
[TBL] [Abstract][Full Text] [Related]
5. Tumor hypoxia and expression of c-met in cervical cancer.
Leo C; Horn LC; Einenkel J; Hentschel B; Höckel M
Gynecol Oncol; 2007 Jan; 104(1):181-5. PubMed ID: 16996116
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in early stage cervical cancer.
Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
[TBL] [Abstract][Full Text] [Related]
7. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
10. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
13. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
15. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
16. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
17. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
[TBL] [Abstract][Full Text] [Related]
18. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
[TBL] [Abstract][Full Text] [Related]
19. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
20. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
